Prioritizing Development A Cost Benefit Analysis of the United Nations' Sustainable Development Goals
Book contents
- Prioritizing Development
- Prioritizing Development
- Copyright page
- Contents
- Figures
- Tables
- Boxes
- Contributors
- Foreword
- Introduction
- Chapter 1 Benefits and Costs of Air Pollution Targets for the Post-2015 Development Agenda
- Chapter 2 Targets for Biodiversity and Deforestation
- Chapter 3 Benefits and Costs of the Climate Change Targets for the Post-2015 Development Agenda
- Chapter 4 Beyond Civil War
- Chapter 5 Data Revolution
- Chapter 6 Benefits and Costs of the Education Targets for the Post-2015 Development Agenda
- Chapter 7 Benefits and Costs of the Energy Targets for the Post-2015 Development Agenda
- Chapter 8 Benefits and Costs of the IFF Targets for the Post-2015 Development Agenda
- Chapter 9 Benefits and Costs of the Trade Targets for the Post-2015 Development Agenda
- Chapter 10 Benefits and Costs of the Health Targets for the Post-2015 Development Agenda
- Chapter 11 Benefits and Costs of the Noncommunicable Disease Targets for the Post-2015 Development Agenda
- Chapter 12 Benefits and Costs of the Women’s Health Targets for the Post-2015 Development Agenda
- Chapter 13 Benefits and Costs of TB Control for the Post-2015 Development Agenda
- Chapter 14 Benefits and Costs of the Infant Mortality Targets for the Post-2015 Development Agenda
- Chapter 15 Benefits and Costs of the HIV/AIDS Targets for the Post-2015 Development Agenda
- Chapter 16 Benefits and Costs of the Malaria Targets for the Post-2015 Consensus Project
- Chapter 17 Benefits and Costs of Digital Technology
- Chapter 18 Returns to Investment in Reducing Postharvest Food Losses and Increasing Agricultural Productivity Growth
- Chapter 19 Benefits and Costs of the Gender Equality Targets for the Post-2015 Development Agenda
- Chapter 20 Benefits and Costs of the Food and Nutrition Targets for the Post-2015 Development Agenda
- Chapter 21 Benefits and Costs of the Population and Demography Targets for the Post-2015 Development Agenda
- Chapter 22 Benefits and Costs of Two Science and Technology Targets for the Post-2015 Development Agenda
- Chapter 23 Global Benefits and Costs of Achieving Universal Coverage of Basic Water and Sanitation Services as part of the 2030 Agenda for Sustainable Development
- Chapter 24 Benefits and Costs of the Poverty Targets for the Post-2015 Development Agenda
- Chapter 25 Good Governance and the Sustainable Development Goals
- Conclusion
- Index
- References
Chapter 11 - Benefits and Costs of the Noncommunicable Disease Targets for the Post-2015 Development Agenda
Published online by Cambridge University Press: 30 May 2018
Edited by
Book contents
- Prioritizing Development
- Prioritizing Development
- Copyright page
- Contents
- Figures
- Tables
- Boxes
- Contributors
- Foreword
- Introduction
- Chapter 1 Benefits and Costs of Air Pollution Targets for the Post-2015 Development Agenda
- Chapter 2 Targets for Biodiversity and Deforestation
- Chapter 3 Benefits and Costs of the Climate Change Targets for the Post-2015 Development Agenda
- Chapter 4 Beyond Civil War
- Chapter 5 Data Revolution
- Chapter 6 Benefits and Costs of the Education Targets for the Post-2015 Development Agenda
- Chapter 7 Benefits and Costs of the Energy Targets for the Post-2015 Development Agenda
- Chapter 8 Benefits and Costs of the IFF Targets for the Post-2015 Development Agenda
- Chapter 9 Benefits and Costs of the Trade Targets for the Post-2015 Development Agenda
- Chapter 10 Benefits and Costs of the Health Targets for the Post-2015 Development Agenda
- Chapter 11 Benefits and Costs of the Noncommunicable Disease Targets for the Post-2015 Development Agenda
- Chapter 12 Benefits and Costs of the Women’s Health Targets for the Post-2015 Development Agenda
- Chapter 13 Benefits and Costs of TB Control for the Post-2015 Development Agenda
- Chapter 14 Benefits and Costs of the Infant Mortality Targets for the Post-2015 Development Agenda
- Chapter 15 Benefits and Costs of the HIV/AIDS Targets for the Post-2015 Development Agenda
- Chapter 16 Benefits and Costs of the Malaria Targets for the Post-2015 Consensus Project
- Chapter 17 Benefits and Costs of Digital Technology
- Chapter 18 Returns to Investment in Reducing Postharvest Food Losses and Increasing Agricultural Productivity Growth
- Chapter 19 Benefits and Costs of the Gender Equality Targets for the Post-2015 Development Agenda
- Chapter 20 Benefits and Costs of the Food and Nutrition Targets for the Post-2015 Development Agenda
- Chapter 21 Benefits and Costs of the Population and Demography Targets for the Post-2015 Development Agenda
- Chapter 22 Benefits and Costs of Two Science and Technology Targets for the Post-2015 Development Agenda
- Chapter 23 Global Benefits and Costs of Achieving Universal Coverage of Basic Water and Sanitation Services as part of the 2030 Agenda for Sustainable Development
- Chapter 24 Benefits and Costs of the Poverty Targets for the Post-2015 Development Agenda
- Chapter 25 Good Governance and the Sustainable Development Goals
- Conclusion
- Index
- References
Summary
We discuss the role of NCDs in the development goal discourse, especially how NCDs fit into the overall health goal and why it is essential to have an NCD target in order to meet Goal 3 of the proposed SDGs: Ensure healthy lives and promote well-being for all at all ages. The interventions presented and analyzed here will reduce mortality by 28.5% in 2030, primarily from cardiovascular and respiratory diseases, as well as some cancers.
- Type
- Chapter
- Information
- Prioritizing DevelopmentA Cost Benefit Analysis of the United Nations' Sustainable Development Goals, pp. 231 - 243Publisher: Cambridge University PressPrint publication year: 2018
References
Ali, MK, Rabadán-Diehl, C, Flanigan, J, et al. 2013. Systems and capacity to address noncommunicable diseases in low-and middle-income countries. Science Translational Medicine 5(181): 181cm4–cm4.CrossRefGoogle ScholarPubMed
Alleyne, G, Nishtar, S. 2013. Sectoral cooperation for the prevention and control of non-communicable diseases. In: Galambos, L, Sturchio, JL, eds. Addressing the Gaps in Global Policy and Research for Non-Communicable Diseases. Baltimore, MD: Johns Hopkins University.Google Scholar
Alwan, A. 2011. Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organization.Google Scholar
Asaria, P, Chisholm, D, Mathers, C, Ezzati, M, Beaglehole, R. 2007. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. The Lancet 370(9604): 2044–53.Google Scholar
Barton, P, Andronis, L, Briggs, A, McPherson, K, Capewell, S. 2011. Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study. BMJ 343.CrossRefGoogle ScholarPubMed
Bertram, Y, Steyn, K, Wentze-Viljoen, E, Tollman, S, Hofman, J. 2012. Reducing the sodium content of high-salt foods: effect on cardiovascular disease in South Africa. SAMJ: South African Medical Journal 102(9): 743–5.CrossRefGoogle ScholarPubMed
Blecher, E, Van Walbeek, C. 2004. An international analysis of cigarette affordability. Tobacco Control 13(4): 339–46.Google Scholar
Bloom, D, Cafiero, E, Jané-Llopis, E, et al. 2011. The Global Economic Burden of Non-Communicable Diseases. Geneva: World Economic Forum.Google Scholar
Bukhman, G, Kidder, A (eds.). 2013. The PIH Guide to Chronic Care Integration for Endemic Non-Communicable Diseases. Boston, MA: Partners in Health.Google Scholar
Commission, OM. 2013. Now for the Long Term, the Report of the Oxford Martin Commission for Future Generations. University of Oxford.Google Scholar
CVD. Prevention Roadmap Summit. www.world-heart-federation.org/publications/heart-beat-e-newsletter/heart-beat-july-2014/advocacy-news/cvd-roadmap/ (accessed January 5, 2015).Google Scholar
Galambos, L, Sturchio, JL, Whitehead, RC. 2013. Noncommunicable Diseases in the Developing World: Addressing Gaps in Global Policy and Research. Baltimore, MD: Johns Hopkins University Press.CrossRefGoogle Scholar
Gaziano, TA, Opie, LH, Weinstein, MC. 2006. Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis. The Lancet 368(9536): 679–86.CrossRefGoogle ScholarPubMed
Gaziano, T., Suhrcke, M, Brouwer, Elizabeth, Levin, Carol, Nikolic, Irinia, Nugent, Rachel. 2017. Costs and cost-effectiveness of interventions and policies to prevent and treat cardiovascular and respiratory diseases, Chapter 19 in Cardiovascular, Respiratory, and Related Diseases, Volume 5 in Disease Control Priorities, 3rd Edition, World Bank.Google Scholar
Hum, R, Jordan, K, Gauvreau, CL, Jha, P. 2015. Health: reducing premature mortality by 40% in the post-2015 consensus. Copenhagen Consensus.Google Scholar
Jha, P, Chaloupka, FJ. 2000. The economics of global tobacco control. BMJ: British Medical Journal 321(7257): 358.CrossRefGoogle ScholarPubMed
Jha, P, Jacob, B, Gajalakshmi, V, et al. 2008. A nationally representative case–control study of smoking and death in India. New England Journal of Medicine 358(11): 1137–47.CrossRefGoogle ScholarPubMed
Jha, P, Nugent, R, Verguet, S, Bloom, D, Hum, R. Chronic Disease Prevention and Control. Copenhagen Consensus 2012 Challenge Paper. 2012.CrossRefGoogle Scholar
Jha, P, Peto, R. 2014. Global effects of smoking, of quitting, and of taxing tobacco. New England Journal of Medicine 370(1): 60–8.Google Scholar
Kankeu, HT, Saksena, P, Xu, K, Evans, DB. 2013. The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Research Policy and Systems 11: 31.CrossRefGoogle ScholarPubMed
Kerr, AJ, Broad, J, Wells, S, Riddell, T, Jackson, R. 2009. Should the first priority in cardiovascular risk management be those with prior cardiovascular disease? Heart 95(2): 125–9.CrossRefGoogle ScholarPubMed
Kontis, V, Mathers, CD, Rehm, J, et al. 2014. Contribution of six risk factors to achieving the 25× 25 non-communicable disease mortality reduction target: a modelling study. The Lancet.CrossRefGoogle Scholar
Kotseva, K, Wood, D, De Backer, G, et al. 2009. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. The Lancet 373(9667): 929–40.CrossRefGoogle Scholar
Lamptey, P, Merson, M, Piot, P, Reddy, KS, Dirks, R. 2011. Informing the 2011 UN Session on Noncommunicable Diseases: applying lessons from the AIDS response. PLoS Medicine 8(9): e1001086.Google Scholar
Lim, SS, Gaziano, TA, Gakidou, E, et al. 2007. Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. The Lancet 370(9604): 2054–62.CrossRefGoogle ScholarPubMed
Lim, SS, Vos, T, Flaxman, AD, et al. 2013. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. The Lancet 380(9859): 2224–60.Google Scholar
Liu, B-Q, Peto, R, Chen, Z-M, et al. 1998. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ 317(7170): 1411–22.CrossRefGoogle Scholar
Mattke, S. 2013. Learning from the HIV/AIDS experience to improve NCD interventions. In: Galambos, L, Sturchio, JL, eds. Addressing the Gaps in Global Policy and Research for Non-Communicable Diseases. Baltimore, MD: Johns Hopkins University.Google Scholar
Murray, CJ, Lopez, AD. 2013. Measuring the global burden of disease. New England Journal of Medicine 369(5): 448–57.Google Scholar
Narain, JP. 2011. Integrating services for noncommunicable diseases prevention and control: Use of primary health care approach. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive & Social Medicine 36(Suppl1): S67.CrossRefGoogle ScholarPubMed
Norheim, OF, Jha, P, Admasu, K, et al. 2014. Avoiding 40% of the premature deaths in each country, 2010–30: review of national mortality trends to help quantify the UN Sustainable Development Goal for health. The Lancet 385(9964): 239–52.Google Scholar
Nugent, RA, Jamison, DT. 2011. What can a UN health summit do? Science Translational Medicine 3(100): 100cm25–cm25.Google Scholar
Olsen, M, et al. 2016. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. The Lancet 388(10060): 2665–2712.Google Scholar
Rubinstein, A, Colantonio, L, Bardach, A, et al. 2010. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina. BMC Public Health 10(1): 627.CrossRefGoogle ScholarPubMed
Salomon, JA, Carvalho, N, Gutiérrez-Delgado, C, et al. 2012. Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis. BMJ 344.Google Scholar
Shiffman, J. 2009. A social explanation for the rise and fall of global health issues. Bulletin of the World Health Organization 87: 608–13.Google Scholar
Shiffman, J. 2010. A framework on generating political priority for global health issues. Injury Prevention 16(Suppl 1): A280–A.CrossRefGoogle Scholar
Smith, L, Yadav, P. 2013. Improving access to medicines for non-communicable diseases through better supply chains. In: Galambos, L, Sturchio, JL, eds. Addressing the Gaps in Global Policy and Research for Non-Communicable Diseases. Baltimore, MD: Johns Hopkins University.Google Scholar
Sridhar, D, Brolan, CE, Durrani, S, et al. 2013. Recent shifts in global governance: implications for the response to non-communicable diseases. PLoS Medicine 10(7): e1001487.CrossRefGoogle ScholarPubMed
Sweeney, S, Obure, CD, Maier, CB, Greener, R, Dehne, K, Vassall, A. 2011. Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experience. Sexually Transmitted Infections 88(2): 85–99.Google Scholar
United Nations General Assembly. 2011. Political declaration of the high level meeting of the general assembly on the prevention and control of non-communicable diseases. United Nations General Assembly. New York, NY.Google Scholar
Vassall, A. 2014. Benefits and costs of the tuberculosis targets for the post-2015 development agenda. Copenhagen Consensus.Google Scholar
Wang, G, Labarthe, D. 2011. The cost-effectiveness of interventions designed to reduce sodium intake. Journal of Hypertension 29(9): 1693–9.CrossRefGoogle ScholarPubMed
WHO Global Health Estimates. 2013. Summary Tables: Projection of Deaths by Cause, Age, and Sex. July 2013 ed. Geneva: World Health Organization.Google Scholar
Wood, J, Babbington, G. 2011. Healthcare in Asia: The Innovation Imperative. London: The Economist.Google Scholar
World Health Organization. 2011. From burden to “best buys”: Reducing the economic impact of non-communicable diseases in low- and middle-income countries, 2015 Global Status Report on NCDs. Geneva, Switzerland: World Health Organization, World Economic Forum.Google Scholar
World Health Organization. 2013a. Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases. Geneva: World Health Organization.Google Scholar
World Health Organization. 2013b. A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis. Geneva: World Health Organization.Google Scholar
World Health Organization. 2013c. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. World Health Organization.Google Scholar
World Health Organization. 2013d. WHO Report on the Global Tobacco Epidemic, 2013: Enforcing Bans on Tobacco Advertising, Promotion and Sponsorship. Geneva: World Health Organization.Google Scholar
Yusuf, S, Islam, S, Chow, CK, et al. 2011. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. The Lancet 378(9798): 1231–43.CrossRefGoogle ScholarPubMed
Yusuf, S. 2002. Two decades of progress in preventing vascular disease. The Lancet 360(9326): 2–3.Google Scholar
- 1
- Cited by